Systemic side effects of eye drops: a pharmacokinetic perspective

When administering eye drops, even when completely correctly applied, several routes of absorption are possible and excess amounts can sometimes cause an unwanted systemic bioavailability of the drops when not completely absorbed into the eye. Furthermore, the concentration of active ingredients in...

Full description

Saved in:
Bibliographic Details
Published in:Clinical ophthalmology (Auckland, N.Z.) N.Z.), 2016-01, Vol.10, p.2433-2441
Main Authors: Farkouh, Andre, Frigo, Peter, Czejka, Martin
Format: Article
Language:English
Subjects:
Analysis
Asthma
Bioavailability
children
Complications and side effects
dosing
Drug dosages
Drug therapy
eye drops
Gene expression
Glaucoma
Liver
Nonsteroidal anti-inflammatory drugs
Ophthalmic drugs
Ophthalmology
Pediatrics
Pharmacokinetics
Physiological aspects
Review
systemic side effects
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c576t-a337ac6073d13a15b6e24b5ed430aca0b19847a46b4eeedfcc8d6bc174dca4fd3
cites
container_end_page 2441
container_issue
container_start_page 2433
container_title Clinical ophthalmology (Auckland, N.Z.)
container_volume 10
creator Farkouh, Andre
Frigo, Peter
Czejka, Martin
description When administering eye drops, even when completely correctly applied, several routes of absorption are possible and excess amounts can sometimes cause an unwanted systemic bioavailability of the drops when not completely absorbed into the eye. Furthermore, the concentration of active ingredients in such medicinal preparations is usually very high, so that despite the correct application of the recommended dose, considerable amounts may be absorbed in an unwanted manner through various routes. Children are subject to a much higher risk of systemic side effects because ocular dosing is not weight adjusted and physiological development (eg, liver status) differs from that of adults. There is a lack of information about pediatric dosing in the current literature. This review summarizes the most important clinically relevant systemic side effects that may occur during ophthalmic eye treatments. In this review, we discuss general pharmacokinetic considerations as well as the advantages, disadvantages, and consequences of administering drugs from some important drug groups to the eye.
doi_str_mv 10.2147/OPTH.S118409
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_7343677b1e854868bb95b89062c1339d</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A506622682</galeid><doaj_id>oai_doaj_org_article_7343677b1e854868bb95b89062c1339d</doaj_id><sourcerecordid>A506622682</sourcerecordid><originalsourceid>FETCH-LOGICAL-c576t-a337ac6073d13a15b6e24b5ed430aca0b19847a46b4eeedfcc8d6bc174dca4fd3</originalsourceid><addsrcrecordid>eNptkk2LFDEQhhtR3A-9eZYGQfbgjPlO2oMwLOouLKyw6zmkk-qZjN2d3qRnYf69aWccd0RySKg89Sb1VhXFG4zmBDP58fb7_dX8DmPFUPWsOMVYyhlnij4_nIU8Kc5SWiMkCFLyZXFCZFUxRuVpsbjbphE6b8vkHZTQNGDHVIamhC2ULoYhfSpNOaxM7IwNP30PY4YHiGnIpH-EV8WLxrQJXu_38-LH1y_3l1ezm9tv15eLm5nlUowzQ6k0ViBJHaYG81oAYTUHxygy1qAaV4pJw0TNAMA11ionaoslc9awxtHz4nqn64JZ6yH6zsStDsbr34EQl9rE_LcWtKSMCilrDCo7IVRdV7xWVS7fYkqrSevzTmvY1B04C_0YTXskenzT-5VehkfNMadE8CxwsReI4WEDadSdTxba1vQQNkljxTGpBKqqjL77B12HTeyzVZoQwinKnWB_qaXJBfi-CfldO4nqBUdCECIUydT8P1Rebmph6KHxOX6U8P5JwgpMO65SaDejD306Bj_sQBtDShGagxkY6WnO9DRnej9nGX_71MAD_Gew6C-CnMtS</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2225309444</pqid></control><display><type>article</type><title>Systemic side effects of eye drops: a pharmacokinetic perspective</title><source>Taylor &amp; Francis Open Access</source><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Farkouh, Andre ; Frigo, Peter ; Czejka, Martin</creator><creatorcontrib>Farkouh, Andre ; Frigo, Peter ; Czejka, Martin</creatorcontrib><description>When administering eye drops, even when completely correctly applied, several routes of absorption are possible and excess amounts can sometimes cause an unwanted systemic bioavailability of the drops when not completely absorbed into the eye. Furthermore, the concentration of active ingredients in such medicinal preparations is usually very high, so that despite the correct application of the recommended dose, considerable amounts may be absorbed in an unwanted manner through various routes. Children are subject to a much higher risk of systemic side effects because ocular dosing is not weight adjusted and physiological development (eg, liver status) differs from that of adults. There is a lack of information about pediatric dosing in the current literature. This review summarizes the most important clinically relevant systemic side effects that may occur during ophthalmic eye treatments. In this review, we discuss general pharmacokinetic considerations as well as the advantages, disadvantages, and consequences of administering drugs from some important drug groups to the eye.</description><identifier>ISSN: 1177-5467</identifier><identifier>ISSN: 1177-5483</identifier><identifier>EISSN: 1177-5483</identifier><identifier>DOI: 10.2147/OPTH.S118409</identifier><identifier>PMID: 27994437</identifier><language>eng</language><publisher>New Zealand: Dove Medical Press Limited</publisher><subject>Analysis ; Asthma ; Bioavailability ; children ; Complications and side effects ; dosing ; Drug dosages ; Drug therapy ; eye drops ; Gene expression ; Glaucoma ; Liver ; Nonsteroidal anti-inflammatory drugs ; Ophthalmic drugs ; Ophthalmology ; Pediatrics ; Pharmacokinetics ; Physiological aspects ; Review ; systemic side effects</subject><ispartof>Clinical ophthalmology (Auckland, N.Z.), 2016-01, Vol.10, p.2433-2441</ispartof><rights>COPYRIGHT 2016 Dove Medical Press Limited</rights><rights>2016. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2016 Farkouh et al. This work is published and licensed by Dove Medical Press Limited 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c576t-a337ac6073d13a15b6e24b5ed430aca0b19847a46b4eeedfcc8d6bc174dca4fd3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2225309444/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2225309444?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27994437$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Farkouh, Andre</creatorcontrib><creatorcontrib>Frigo, Peter</creatorcontrib><creatorcontrib>Czejka, Martin</creatorcontrib><title>Systemic side effects of eye drops: a pharmacokinetic perspective</title><title>Clinical ophthalmology (Auckland, N.Z.)</title><addtitle>Clin Ophthalmol</addtitle><description>When administering eye drops, even when completely correctly applied, several routes of absorption are possible and excess amounts can sometimes cause an unwanted systemic bioavailability of the drops when not completely absorbed into the eye. Furthermore, the concentration of active ingredients in such medicinal preparations is usually very high, so that despite the correct application of the recommended dose, considerable amounts may be absorbed in an unwanted manner through various routes. Children are subject to a much higher risk of systemic side effects because ocular dosing is not weight adjusted and physiological development (eg, liver status) differs from that of adults. There is a lack of information about pediatric dosing in the current literature. This review summarizes the most important clinically relevant systemic side effects that may occur during ophthalmic eye treatments. In this review, we discuss general pharmacokinetic considerations as well as the advantages, disadvantages, and consequences of administering drugs from some important drug groups to the eye.</description><subject>Analysis</subject><subject>Asthma</subject><subject>Bioavailability</subject><subject>children</subject><subject>Complications and side effects</subject><subject>dosing</subject><subject>Drug dosages</subject><subject>Drug therapy</subject><subject>eye drops</subject><subject>Gene expression</subject><subject>Glaucoma</subject><subject>Liver</subject><subject>Nonsteroidal anti-inflammatory drugs</subject><subject>Ophthalmic drugs</subject><subject>Ophthalmology</subject><subject>Pediatrics</subject><subject>Pharmacokinetics</subject><subject>Physiological aspects</subject><subject>Review</subject><subject>systemic side effects</subject><issn>1177-5467</issn><issn>1177-5483</issn><issn>1177-5483</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptkk2LFDEQhhtR3A-9eZYGQfbgjPlO2oMwLOouLKyw6zmkk-qZjN2d3qRnYf69aWccd0RySKg89Sb1VhXFG4zmBDP58fb7_dX8DmPFUPWsOMVYyhlnij4_nIU8Kc5SWiMkCFLyZXFCZFUxRuVpsbjbphE6b8vkHZTQNGDHVIamhC2ULoYhfSpNOaxM7IwNP30PY4YHiGnIpH-EV8WLxrQJXu_38-LH1y_3l1ezm9tv15eLm5nlUowzQ6k0ViBJHaYG81oAYTUHxygy1qAaV4pJw0TNAMA11ionaoslc9awxtHz4nqn64JZ6yH6zsStDsbr34EQl9rE_LcWtKSMCilrDCo7IVRdV7xWVS7fYkqrSevzTmvY1B04C_0YTXskenzT-5VehkfNMadE8CxwsReI4WEDadSdTxba1vQQNkljxTGpBKqqjL77B12HTeyzVZoQwinKnWB_qaXJBfi-CfldO4nqBUdCECIUydT8P1Rebmph6KHxOX6U8P5JwgpMO65SaDejD306Bj_sQBtDShGagxkY6WnO9DRnej9nGX_71MAD_Gew6C-CnMtS</recordid><startdate>20160101</startdate><enddate>20160101</enddate><creator>Farkouh, Andre</creator><creator>Frigo, Peter</creator><creator>Czejka, Martin</creator><general>Dove Medical Press Limited</general><general>Taylor &amp; Francis Ltd</general><general>Dove Medical Press</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20160101</creationdate><title>Systemic side effects of eye drops: a pharmacokinetic perspective</title><author>Farkouh, Andre ; Frigo, Peter ; Czejka, Martin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c576t-a337ac6073d13a15b6e24b5ed430aca0b19847a46b4eeedfcc8d6bc174dca4fd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Analysis</topic><topic>Asthma</topic><topic>Bioavailability</topic><topic>children</topic><topic>Complications and side effects</topic><topic>dosing</topic><topic>Drug dosages</topic><topic>Drug therapy</topic><topic>eye drops</topic><topic>Gene expression</topic><topic>Glaucoma</topic><topic>Liver</topic><topic>Nonsteroidal anti-inflammatory drugs</topic><topic>Ophthalmic drugs</topic><topic>Ophthalmology</topic><topic>Pediatrics</topic><topic>Pharmacokinetics</topic><topic>Physiological aspects</topic><topic>Review</topic><topic>systemic side effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Farkouh, Andre</creatorcontrib><creatorcontrib>Frigo, Peter</creatorcontrib><creatorcontrib>Czejka, Martin</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>ProQuest research library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>Clinical ophthalmology (Auckland, N.Z.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Farkouh, Andre</au><au>Frigo, Peter</au><au>Czejka, Martin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Systemic side effects of eye drops: a pharmacokinetic perspective</atitle><jtitle>Clinical ophthalmology (Auckland, N.Z.)</jtitle><addtitle>Clin Ophthalmol</addtitle><date>2016-01-01</date><risdate>2016</risdate><volume>10</volume><spage>2433</spage><epage>2441</epage><pages>2433-2441</pages><issn>1177-5467</issn><issn>1177-5483</issn><eissn>1177-5483</eissn><abstract>When administering eye drops, even when completely correctly applied, several routes of absorption are possible and excess amounts can sometimes cause an unwanted systemic bioavailability of the drops when not completely absorbed into the eye. Furthermore, the concentration of active ingredients in such medicinal preparations is usually very high, so that despite the correct application of the recommended dose, considerable amounts may be absorbed in an unwanted manner through various routes. Children are subject to a much higher risk of systemic side effects because ocular dosing is not weight adjusted and physiological development (eg, liver status) differs from that of adults. There is a lack of information about pediatric dosing in the current literature. This review summarizes the most important clinically relevant systemic side effects that may occur during ophthalmic eye treatments. In this review, we discuss general pharmacokinetic considerations as well as the advantages, disadvantages, and consequences of administering drugs from some important drug groups to the eye.</abstract><cop>New Zealand</cop><pub>Dove Medical Press Limited</pub><pmid>27994437</pmid><doi>10.2147/OPTH.S118409</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1177-5467
ispartof Clinical ophthalmology (Auckland, N.Z.), 2016-01, Vol.10, p.2433-2441
issn 1177-5467
1177-5483
1177-5483
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_7343677b1e854868bb95b89062c1339d
source Taylor & Francis Open Access; Publicly Available Content Database; PubMed Central
subjects Analysis
Asthma
Bioavailability
children
Complications and side effects
dosing
Drug dosages
Drug therapy
eye drops
Gene expression
Glaucoma
Liver
Nonsteroidal anti-inflammatory drugs
Ophthalmic drugs
Ophthalmology
Pediatrics
Pharmacokinetics
Physiological aspects
Review
systemic side effects
title Systemic side effects of eye drops: a pharmacokinetic perspective
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T15%3A57%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Systemic%20side%20effects%20of%20eye%20drops:%20a%20pharmacokinetic%20perspective&rft.jtitle=Clinical%20ophthalmology%20(Auckland,%20N.Z.)&rft.au=Farkouh,%20Andre&rft.date=2016-01-01&rft.volume=10&rft.spage=2433&rft.epage=2441&rft.pages=2433-2441&rft.issn=1177-5467&rft.eissn=1177-5483&rft_id=info:doi/10.2147/OPTH.S118409&rft_dat=%3Cgale_doaj_%3EA506622682%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c576t-a337ac6073d13a15b6e24b5ed430aca0b19847a46b4eeedfcc8d6bc174dca4fd3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2225309444&rft_id=info:pmid/27994437&rft_galeid=A506622682&rfr_iscdi=true